lundi 27 avril 2020

Onco Actu du 27 avril 2020


5. TRAITEMENTS



Understanding Risk and Improving Treatment for Testicular Cancer [Cancer Research Catalyst]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Preventing metastasis - an antibody with therapeutic potential [DKFZ]











5.12.5 IMMUNOTHÉRAPIES - PHARMA



GSK posts middling data from PD-1 Tesaro buyout drug [Fierce Pharma]











GSK flashes positive data for Tesaro drug that could become 7th approved PD-(L)1 [EndPoints]











5.2 PHARMA



Lynparza improves survival rate in prostate cancer, giving AstraZeneca and Merck another win on PARP front [EndPoints]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



FDA Grants Accelerated Approval to Sacituzumab Govitecan-hziy for Metastatic TNBC [ESMO]











5.9 AACR



AACR Virtual Annual Meeting I: A User’s Guide [AACR]











5.9.3 AACR - MÉLANOME



On-off dosing of cancer drugs does not help melanoma patients [Science]










AACR: Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression [Fierce Pharma]










6.15 LUTTE CONTRE LES CANCERS - COVID-19



New Clinical Trial Data, Initiatives, and Path Forward for Post-COVID-19 Cancer Care Delivery System Announced [ASCO]










Coronavirus (Covid-19) and cancer patients: How the sickest are affected [Clear Health Costs]